Cite
HARVARD Citation
Scott, F. et al. (2018). Assessing the Optimal Position for Vedolizumab in the Treatment of Ulcerative Colitis. Inflammatory bowel diseases. 24 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Scott, F. et al. (2018). Assessing the Optimal Position for Vedolizumab in the Treatment of Ulcerative Colitis. Inflammatory bowel diseases. 24 (2), p. . [Online].